5 reports

This year, the wholly owned subsidiary cell pharm launched the filgrastim product Grastrofil.

  • Interferon
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited

PEG-FILGRASTIM (PEG-GCSF) MARKETED AS NEUPOGEN BY AMGEN, INC.

  • Biotechnology
  • Interferon
  • Pharmaceutical
  • North America
  • JenKem Technology Co., Ltd
  • and Table 17.87 shows the likely growth for the global G-CSF/ GM-CSF
  • GLOBAL G-CSF/GM-CSF BIOSIMILARS MARKET FORECAST: DISTRIBUTION BY REGION, 2020 AND 2025 (USD BILLION)

FILGRASTIM ##. ##. ##.

  • Interferon
  • Asia
  • Europe
  • World
  • Market Size

filgrastim; methylprednisolone Uppsala County Council ## Mar 2011 ## Mar 2016 ## ## Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Mesenchymal Stem Cell Therapy for Canadian MS Patients Safety and Efficacy of Intravenous Au

  • Clinical Trial
  • Hospital
  • Interferon
  • Neurological Disorder
  • Biogen Idec Inc.

Granulocyte Colony Page## BLOOD DISEASE DRUGS PRODUCER DIRECTORY stimulating Factor (Filgrastim, rHuG-CSF) and Interleukin ##(rHuIL-##), etc.

  • Interferon
  • China
  • Demand
  • Market Size
  • Shanghai Schering-Plough Pharmaceutical Company, Ltd